Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Asher Alban Chanan-KhanP G Richardson

Abstract

The aim of this subset analysis was to determine if bortezomib treatment is associated with increased incidence of varicella-zoster virus (VZV) reactivation in patients with relapsed multiple myeloma (MM). Incidence of herpes zoster was evaluated in 663 patients with relapsed MM from the phase III APEX trial comparing single-agent bortezomib with high-dose dexamethasone. Bortezomib was associated with a significantly higher incidence of herpes zoster compared with dexamethasone treatment (13%, 42 of 331 v 5%, 15 of 332; P = .0002). Most herpes zoster infections were grade 1/2; incidences of grade 3/4 events (1.8% v 1.5%) and infections considered serious adverse events (1.5% v 0.9%) were similar between treatment arms, and no herpes zoster-related deaths occurred. Neither the time to onset of the herpes event nor the patients' absolute lymphocyte counts at baseline differed significantly between arms. VZV reactivation was the only herpes viral event noted to be significantly elevated in the bortezomib treatment group compared with the dexamethasone treatment group (P = .0002). The incidence of non-VZV-related herpes viral infections was comparable between arms. No additional risk factors for herpes zoster reactivation were iden...Continue Reading

References

Mar 21, 1998·British Journal of Haematology·N E KayM M Oken
Jun 22, 1999·Annals of Internal Medicine·J I CohenP R Krause
Aug 10, 2002·Journal of Cellular and Molecular Medicine·S KumarS V Rajkumar
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Oct 29, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Paul G RichardsonKenneth C Anderson
Oct 30, 2003·Viral Immunology·Donald H GildenRavi Mahalingam
Dec 5, 2003·Lancet·Michail S Lionakis, Dimitrios P Kontoyiannis
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kai SunWilliam J Murphy
Oct 6, 2004·British Journal of Haematology·S JagannathK C Anderson
Jan 18, 2005·Clinical Microbiology Reviews·Sophie Hambleton, Anne A Gershon
May 26, 2005·International Journal of Hematology·Yoshiaki KurodaAkiro Kimura
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Aug 17, 2005·Cancer Research·Hiroshi YasuiKenneth C Anderson
Feb 16, 2006·European Journal of Immunology·Alessio NencioniAlberto Ballestrero
Nov 30, 2006·American Journal of Hematology·Yin TongJie Jin

❮ Previous
Next ❯

Citations

Mar 10, 2010·Medical Oncology·Tiffany Richards, Donna Weber
Dec 27, 1995·Biochimica Et Biophysica Acta·G LépineD Pallotta
Oct 12, 2010·The Lancet Oncology·Michel DelforgePieter Sonneveld
Sep 11, 2009·Leukemia·J J Shah, R Z Orlowski
Jun 9, 2012·Leukemia·D H VesoleUNKNOWN University of Rochester Cancer Center and the Eastern Cooperative Oncology Group
Nov 18, 2011·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Hongfeng GuoHongli Sun
May 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D H T MyaD C L Tan
Jan 18, 2011·Hematology·Pieter Sonneveld, Joost L M Jongen
Jun 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven P TreonIrene M Ghobrial
Jan 1, 2009·Cancer Management and Research·Jacob P LaubachPaul G Richardson
Dec 11, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·C T KouroukisM C Cheung
Apr 6, 2013·Immunotherapy·Alessandra RomanoFrancesco Di Raimondo
Sep 13, 2014·Hematology/oncology Clinics of North America·Silvia Gentili, Sagar Lonial
Oct 30, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vicki A Morrison
Feb 18, 2016·British Journal of Cancer·Hua WangYue Lu
Dec 24, 2015·Leukemia & Lymphoma·Anat Gafter-Gvili, Aaron Polliack
Oct 23, 2015·Expert Review of Anti-infective Therapy·Benjamin W TehLeon J Worth
Aug 2, 2011·Expert Review of Hematology·Javier de la Rubia, Mónica Roig
Jul 10, 2014·Expert Opinion on Drug Safety·Hui WangHuanjie Yang
Jun 10, 2009·Expert Opinion on Investigational Drugs·Huanjie YangQ Ping Dou
Apr 30, 2013·Blood Reviews·Antonio Palumbo, Roberto Mina
Mar 27, 2015·European Journal of Haematology·Tetsuo HasegawaTomonori Nakazato
Jul 28, 2015·American Journal of Hematology·Wilson I GonsalvesLuciano J Costa
Jun 26, 2012·Seminars in Hematology·Eva MoranAlessio Nencioni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

The New England Journal of Medicine
P G RichardsonAssessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Clinical Lymphoma & Myeloma
Seok Jin KimKorean Multiple Myeloma Working Party
The New England Journal of Medicine
Anwarul Islam, Julian L Ambrus
The New England Journal of Medicine
Paul G RichardsonKenneth C Anderson
© 2022 Meta ULC. All rights reserved